Debra N. Yeboa, M.D.
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Yeboa
Dr. Debra Yeboa is an Associate Professor of the Department of Radiation Oncology at MD Anderson Cancer Center. She joined the MD Anderson faculty after completing her medical training at Yale.
Her clinical and research interests lie in advancing the clinical outcomes of patients with brain or spine cancers. Her interests include health outcomes, health services and comparative effectiveness research for brain and spine cancers.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2011 | University of Pennsylvania School of Medicine, Philadelphia, PA, USA, MD, Doctor of Medicine |
Postgraduate Training
| 2015-2016 | Clinical Residency, Radiation Oncology Chief Resident, Yale-New Haven Hospital, New Haven, CT |
| 2012-2015 | Clinical Residency, Radiation Oncology Resident, Yale-New Haven Hospital, New Haven, CT |
| 2011-2012 | Clinical Internship, Transitional Year Internship, Crozer-Chester Medical Center, Philadelphia, PA |
Experience & Service
Administrative Appointments/Responsibilities
CNS Radiation Oncology Section Research Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2019 - Present
CNS Section Resident Education Coordinator, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Chief Resident, Department of Radiation Oncology, Yale-New Haven Hospital Radiation Oncology, New Haven, CT, 2015 - 2016
Other Appointments/Responsibilities
RadOnc Representative, Brain Tumor (BTC) Executive Committee, Houston, TX, 2019 - Present
MDACC Brain and Spine Center Brain Lesion Adult Glioma Algorithm Core Development Team (Yeboa and de Groot), MD Anderson Cancer Center, Houston, TX, 2019 - 2021
Radonc representative, International Teleconference Tumor Board for Sister Networks (Clinica Alemana in Santiago, Chile), MD Anderson Cancer Center, Houston, TX, 2018 - Present
Radonc Liaison, CNS Radiation oncology Multidisciplinary Clinical Neurosciences Lecture Series Organizer, Houston, TX, 2018 - Present
CNS Radonc Liaison, CNS Radiation oncology resident Mock Oral Organizer, Houston, TX, 2018 - Present
PI of application of NCDB Lymphoma, Head and Neck and Sarcoma, GI, Gyn and CNS, Developer of Independent MDACC Radiation Oncology Collaborative HSR Server for NCDB Data, Houston, TX, 2018 - Present
Institutional Committee Activities
Member, MDACC Division of Radiation Oncology Grand Rounds Committee, 2021 - Present
Radiation Oncology Representative, Brain Tumor Center Tissue Utilization Committee, 2019 - Present
Committee Member, MDACC Scientific Review Committee, 2019 - Present
CNS-Pedi Section Representative, MDACC Division of Radiation Oncology Clinical Research Council (RO-CRC), 2019 - Present
Faculty member, MDACC Division of Radiation Oncology Awards Committee, 2018 - Present
Protocol-in-a-Day Chair, MDACC Division of Radiation Oncology, Clinical Research Council (RO-CRC), 2018 - Present
Senator, MD Anderson Cancer Center Faculty Senate, 2017 - Present
Co-President, Yale Minority Housestaff Organization, 2014 - 2015
Co-President, Yale Minority Housestaff Organization, 2013 - 2014
Mentorship Chair, Yale Minority Housestaff Organization, 2012 - 2013
Honors & Awards
| 2022 | James Cox Radiation Oncology Resident Mentorship Award, MDACC |
| 2021 | Robert Wood Johnson Harold Amos Medical Faculty Development Program (AMFD), Finalist/ Recipient |
| 2021 | Trainee Nomination by the Division of Education and Training to Apply for MDACC Internal Review for The UT Systems Regents' Teaching Award, MDACC UT Systems Regents (ROTA) |
| 2021 | Association of American Medical Colleges(AAMC) Awarded Acceptance 2020 Leadership Education and Development Program (LEAD), Association of American Medical Colleges (AAMC), Postponed due to COVID-19 |
| 2020 | American Society of Radiation Oncology (ASTRO) Protégé Leadership Program Awardee, ASTRO |
| 2019 | Mentor to 3rd place MD Anderson Trainee Research Day Oral Competition Award Winner 'Relationship between Treatment Center Case Volume and Outcomes for Ewing Sarcoma Patients: The Role of Local Therapy Timing ', MDACC |
| 2019 | Shirley Stein Scientific Endowment Research Award, Awarded to a member of the MDACC faculty for ‘exceptional clinical research performed by faculty' |
| 2018 | Association of American Medical Colleges (AAMC) Awarded Minority Faculty Leadership Development Seminar Program, Association of American Medical Colleges (AAMC) |
| 2018 | Radiological Society of North America (RSNA)/ Awarded Clinical Trials Methodology Workshop Program 2018-2019, Radiological Society of North America (RSNA) |
| 2017 | Southwest Oncology Group (SWOG) Virtual Grant Writing Workshop Awarded Participant, SWOG/ The Hope Foundation |
| 2016 | Radiological Society of North America (RSNA)/ American Society of Neuroradiology (ASNR) , Awarded Comparative Effectiveness Research Training Program (CERT), Radiological Society of North America (RSNA)/ American Society of Neuroradiology (ASNR) |
| 2011 | John Glick Prize for Translational Cancer Research, UPenn School of Medicine |
| 2009 | Duke Clinical Research Fellowship for Medical Students, UPenn School of Medicine |
| 2006 | Phi Beta Kappa (Honor Society member) |
| 2006 | Gamble (Twenty-First Century) Scholar, UPenn School of Medicine |
| 2004 | President, Beta Kappa Chi (National Scientific Honor Society, Spelman Chap.) |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Hasanov E, Yeboa DN , Tucker MD, Swanson TA, Beckham TH, Rini B, Ene CI, Hasanov M, Derks S, Smits M, Dudani S, Heng DYC, Brastianos PK, Bex A, Hanalioglu S, Weinberg JS, Hirsch L, Carlo MI, Aizer A, Brown PD, Bilen MA, Chang EL, Jaboin J, Brugarolas J, Choueiri TK, Atkins MB, McGregor BA, Halasz LM, Patel TR, Soltys SG, McDermott DF, Elder JB, Baskaya MK, Yu JB, Timmerman R, Kim MM, Mut M, Markert J, Beal K, Tannir NM, Samandouras G, Lang FF, Giles R, Jonasch E. An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma. CA Cancer J Clin 72(5):454-489, 2022. e-Pub 2022. PMID: 35708940.
- Han EY, Wang H, Briere TM, Yeboa DN , Boursianis T, Kalaitzakis G, Pappas E, Castillo P, Yang J. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test. J Appl Clin Med Phys 23(3):e13518, 2022. e-Pub 2022. PMID: 34994101.
- Upadhyay R, Liao K, Grosshans DR, McGovern SL, McAleer MF, Zaky W, Chintagumpala MM, Mahajan A, Yeboa DN , Paulino AC. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. e-Pub 2022. PMID: 35157767.
- Piña Y, Yadugiri S, Yeboa DN , Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep 24(1):43-54, 2022. e-Pub 2022. PMID: 35059999.
- Han EY, Cardenas CE, Nguyen C, Hancock D, Xiao Y, Mumme R, Court LE, Rhee DJ, Netherton TJ, Li J, Yeboa DN , Wang C, Briere TM, Balter P, Martel MK, Wen Z. Clinical implementation of automated treatment planning for whole-brain radiotherapy. J Appl Clin Med Phys 22(9):94-102, 2021. e-Pub 2021. PMID: 34250715.
- Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN , Brock KK, Chung C. The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol 6(4):100708, 2021. e-Pub 2021. PMID: 34124413.
- Taku N, Woodhouse KD, Liao KP, Anakwenze CP, Harrison RA, Zaky W, Paulino AC, Yeboa DN . Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst 37(5):1563-1572, 2021. e-Pub 2021. PMID: 33404712.
- Yeboa DN , Akinfenwa CA, Nguyen J, Amaya D, de Gracia B, Ning M, Cox V, De B, Smith BD, Lin L, Beddar S, Hoang H, Koong A, Liao Z. Effectively Conducting Oncology Clinical Trials during the COVID-19 Pandemic. Adv Radiat Oncol 6(3):100676, 2021. e-Pub 2021. PMID: 33686374.
- De B, Kaiser KW, Ludmir EB, Yeboa DN , Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 60(3):1-4, 2021. e-Pub 2020. PMID: 33356801.
- Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Garcia MM, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN , Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv 3(1):vdab079, 2021. e-Pub 2021. PMID: 34377987.
- Diao K, Song J, Thall PF, McGinnis GJ, Boyce-Fappiano D, Amini B, Brown PD, Yeboa DN , Bishop AJ, Li J, Briere TM, Tatsui CE, Rhines LD, Chang EL, Ghia AJ. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol 152:49-55, 2020. e-Pub 2020. PMID: 32745668.
- Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN . Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 2020. e-Pub 2020. PMID: 32407910.
- Nantavithya C, Paulino AC, Liao K, McGovern SL, Grosshans DR, McAleer MF, Woodhouse KD, Khatua S, Chintagumpala MM, Majd NK, Yeboa DN . Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer 67(8):e28373, 2020. e-Pub 2020. PMID: 32453481.
- Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN , Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
- Gjyshi O, Boyce-Fappiano D, Pezzi TA, Ludmir EB, Xiao L, Kaseb A, Amini B, Yeboa DN , Bishop AJ, Li J, Rhines LD, Tatsui CE, Briere TM, Ghia AJ. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol 148(2):327-334, 2020. e-Pub 2020. PMID: 32358642.
- Milligan MG, Cronin AM, Colson Y, Kehl K, Yeboa DN , Schrag D, Chen AB. Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 18(5):547-554, 2020. PMID: 32380461.
- Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN , Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro Oncol 22(4):577-579, 2020. e-Pub 2020. PMID: 31900480.
- Boyce-Fappiano D, Gjyshi O, Pezzi TA, Allen PK, Solimman M, Taku N, Bernstein MB, Cabanillas ME, Amini B, Tatsui CE, Rhines LD, Wang XA, Briere TM, Yeboa DN , Bishop AJ, Li J, Ghia AJ. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine:1-9. e-Pub 2020. PMID: 32059183.
- de Almeida Bastos DC, Everson RG, de Oliveira Santos BF, Habib A, Vega RA, Oro M, Rao G, Li J, Ghia AJ, Bishop AJ, Yeboa DN, Amini B, Rhines LD, Tatsui CE. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine:1-9. e-Pub 2020. PMID: 31899882.
- Shaverdian N, Yeboa DN , Gardner L, Harari PM, Liao K, McCloskey S, Tuli R, Vapiwala N, Jagsi R. Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences. J Oncol Pract 15(12):e1010-e1017, 2019. e-Pub 2019. PMID: 31747336.
- Traylor JI, Habib A, Patel R, Muir M, Gadot R, Briere T, Yeboa DN, Li J, Rao G. Fractionated stereotactic radiotherapy for local control of resected brain metastases. J Neurooncol 144(2):343-350, 2019. e-Pub 2019. PMID: 31313060.
- Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 2019. e-Pub 2019. PMID: 31150024.
- Lin TA, Ludmir EB, Liao KP, McAleer MF, Grosshans DR, McGovern SL, Bishop AJ, Woodhouse KD, Paulino AC, Yeboa DN. Timing of Local Therapy Impacts Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys 104(1):127-136, 2019. e-Pub 2018. PMID: 30593906.
- Rahimy E, Weidhaas J, Wei W, Lannin D, Horowitz N, Higgins S, Wilson LD, Knowlton C, Moran MS, Young MR, Killelea B, Chagpar A, Yeboa DN, Zelterman D, Evans S. Patient Reported Outcomes and Cosmesis in a Feasibility Study of 4D Simulated Image Guided Accelerated Partial Breast Irradiation (APBI). Pract Radiat Oncol 9(3):e257-e265, 2019. e-Pub 2019. PMID: 30796975.
- Yeboa DN, Liao Z, Court L, Holliday E, Spelman A, Herman J. Protocol-in-a-Day Workshop: A “Lean” Approach to Clinical Trial Development and Focus on Junior Faculty Development. Advances in Radiation Oncology 4(3):439-442, 2019. PMID: doi: 10.1016/j.adro.201.
- Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol 15:46-52, 2019. e-Pub 2018. PMID: 30656222.
- Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Foss FM, Yeboa DN. Cutaneous T-Cell Lymphoma: Trends in Radiation Doses and Patterns of Care 2004-2015. Anticancer Res 39(1):253-259, 2019. PMID: 30591466.
- Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 2019. PMID: 30641236.
- Han EY, Kim GY, Rebueno N, Yeboa DN, Briere TM. End-to-end testing of automatic plan optimization using RayStation scripting for hypofractionated multi-metastatic brain stereotactic radiosurgery. Med Dosim 44(4):e44-e50, 2019. e-Pub 2019. PMID: 30655170.
- Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C. The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. e-Pub 2018. PMID: 30386741.
- Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiother Oncol 125(2):258-265, 2017. e-Pub 2017. PMID: 29054377.
- Kann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clin Lymphoma Myeloma Leuk 17(8):520-526.e2, 2017. e-Pub 2017. PMID: 28655598.
- Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol 19(2):259-269, 2017. e-Pub 2016. PMID: 27540083.
- Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncol 2(12):1574-1581, 2016. e-Pub 2016. PMID: 27491009.
- Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol 39(6):568-574, 2016. e-Pub 2014. PMID: 24879475.
- Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Urology 96:128-135, 2016. e-Pub 2016. PMID: 27392652.
- Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer 122(15):2364-70, 2016. e-Pub 2016. PMID: 27172136.
- Yeboa DN, Evans SB. Contemporary Breast Radiotherapy and Cardiac Toxicity. Semin Radiat Oncol 26(1):71-8, 2016. e-Pub 2015. PMID: 26617212.
- Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 121(23):4141-9, 2015. e-Pub 2015. PMID: 26280559.
- Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Lung Cancer 90(2):243-8, 2015. e-Pub 2015. PMID: 26277031.
- Rutter CE, Lester-Coll NH, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer 121(14):2331-40, 2015. e-Pub 2015. PMID: 25810128.
- Yeboa DN, Aneja S, Montana G, Roberts K, Yu J. Historical Trends in Radiotherapy Use in Prevalent Malignancies over 38 years in SEER. Journal of Radiation Oncology 4(11), 2015. e-Pub 2015.
- Rutter CE, Corso CD, Park HS, Mancini BR, Yeboa DN, Lester-Coll NH, Kim AW, Decker RH. Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States. Lung Cancer 85(3):390-4, 2014. e-Pub 2014. PMID: 25001510.
- Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 81(4):e325-34, 2011. e-Pub 2011. PMID: 21498008.
- Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78(5):1107-13, 2011. e-Pub 2011. PMID: 21943872.
Invited Articles
- Farooqi A, Li J, de Groot J, Yeboa DN . Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors. Hematol Oncol Clin North Am 34(1):13-28, 2020. e-Pub 2019. PMID: 31739940.
- Yeboa DN, Shah AY. Managing Perplexing Intracranial Lesions. Int J Radiat Oncol Biol Phys 105(2):24, 2019. PMID: 31492380.
- Yeboa DN and Sulman E. “Update on radiation combinations in the treatment of patients with malignant brain tumors: from Radiosensitizers to immunotherapy”. World Federation of Neuro-Oncology Societies Magazine, WFNOS Volume 2(Issue 3):ISSN 2518-6507. e-Pub 2017.
Abstracts
- Nantavithya C, Yeboa D, Liao K, McGovern S, Grosshans D, McAleer MF, Woodhouse K, Khatua S, Chintagumpala M, Paulino A. Risk of developing secondary malignancies in patients with medulloblastoma receiving beam radiation, a surveillance, epidemiology, and end results (SEER) analysis. 2018 50th Congress of the International Society of Paediatric Oncology, 2018.
- Nantavithya C, Yeboa D, Liao K, McGovern S, Grosshans D, McAleer MF, Woodhouse K, Khatua S, Chintagumpala M, Paulino A. Secondary malignant neoplasms in patients with medulloblastoma. 2018 American Society for Radiation Oncology (ASTRO), 60th Annual Meeting POSTER VIEWING, 2018.
- Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Yeboa DN. “Higher Volume Facilities are Associated with Lower Dose Radiotherapy in the Treatment of Cutaneous T-Cell Lymphoma”. 2018 American Society for Radiation Oncology (ASTRO), 60th Annual Meeting POSTER VIEWING, 2018.
- Han E, Kim G, Rebeno N, Yeboa D, Wang X, Lee H, Svensson S, Briere T.. E2E test of automatic plan optimization using Raystation scripting for Hypo-fractionated multi-metastatic brain SRS. American Association of Physicists in Medicine National Meeting July 2018 (Nashville TN) Poster, 2018.
- Miccio JA, Wilson LD, Kann BH, Jairam V, Beckta J, Yeboa DN. “Cutaneous T-Cell Lymphoma: Trends in Radiation Dose and Patterns of Care”. 2018 100th American Radium Society Meeting, Orlando FL, May, 5-8,2018, Poster, 2018.
- Kann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Bindra RS, Khan AJ, Marks AM, Roberts KB. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children. Int J Radiat Oncol Biol Phys 96(2S):S230-S231, 2016. PMID: 27675855.
- Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Bindra RS, Becker KP, Baehring J, Roberts KB. Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult Medulloblastoma. Int J Radiat Oncol Biol Phys 96(2S):S27-S28, 2016. PMID: 27675888.
- Rutter CE, Park HSM, Corso CD, Lester-Coll NH, Man BR, Yeboa DN. The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma. Int J Radiat Onc Biol Phys 93(3):S154-S155, 2015.
- Yeboa DN, Rutter CE, Park HSM, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Yu JB. Concurrent Chemoradiation Therapy Is Associated With Improved Survival Compared to Radiation Therapy Alone for Anaplastic Gliomas. Int J Radiat Onc Biol Phys 93(3):S168, 2015.
- An Y, Rutter CE, Park HSM, Stahl JM, Corso CD, Mancini BR, Lester-Coll NH, Yeboa DN, Evans SB. Increasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United States. Int J Radiat Onc Biol Phys 93(3):E50, 2015.
- An Y, Rutter CE, Park HSM, Corso CD, Mancini BR, Lester-Coll NH, Yeboa DN, Evans SB. Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery. Int J Radiat Onc Biol Phys 93(3):E54-E55, 2015.
- Kole AJ, Yeboa DN, Rutter CE, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Yu JB, Park HSM. Survival Benefit of Concurrent Chemoradiation Therapy for Unresected Glioblastoma Multiforme in the Temozolomide Era. Int J Radiat Onc Biol Phys 93(3):E64, 2015.
- Yeboa DN, Park HSM, Rutter CE, Mancini BR, Corso CD, Lester-Coll NH, Bindra RS, Yu JB. Practice Patterns of Concurrent Chemoradiation Therapy Compared to Radiation Therapy Alone for Low Grade Gliomas. Int J Radiat Onc Biol Phys 93(3):E73, 2015.
- Park HSM, Yeboa DN, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Roberts KB, Yu JB. Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide Comparison. International Journal of Radiation Oncology • Biology • Physics 93(3):E504–E505, 2015. e-Pub 2015.
- Lester-Coll NH, Park HSM, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim S, Gross CP, Yu JB. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. Int J Radiat Onc Biol Phys 93(3):S118, 2015.
- Yeboa D, Roberts KB, Aneja S, Yu JB. Historical Trends of Radiation Therapy Use in Prevalent Malignancies. Int J Radiat Onc Biol Phys 90(1):S599-S600, 2014.
- Yeboa D, Yu JB. Impact of the Recession on Radiation Therapy After Lumpectomy for Invasive Breast Cancer. Int J Radiat Onc Biol Phys 87(2):S218, 2013.
- Yeboa DN, Mitra N, Guzzo T, Pollack C, Bekelman J. Subsequent Treatment Outcomes of Men with Localized Prostate Cancer Who Do Not Receive Initial Treatment. Int J Radiat Onc Biol Phys 81(2):S405, 2011.
- Yeboa DN, Sunderland R, Liao K, Armstrong K, Bekelman J. Trends in Treatment with Intensity Modulated (IMRT) vs. 3D Conformal (CRT) Radiotherapy for Non-metastatic Prostate Cancer. Int J Radiat Onc Biol Phys 78(3):S342-S343, 2010.
- Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K. Comparative Effectiveness of Intensity Modulated (IMRT) versus 3D Conformal (CRT) Radiotherapy for Non-metastatic Prostate Cancer. Int J Radiat Onc Biol Phys 78(3):S77, 2010.
- Taku N, Woodhouse K, Liao K, McGovern S, Grosshans D, Paulino A, Yeboa D,. Patterns of care of pediatric patients diagnosed with grade II gliomas. International Journal of Radiation Oncology • Biology • Physics (IJROBP),.
- Ludmir E, Liao K, Bishop A, Lin T, McAleer M, Woodhouse K, Paulino A, Yeboa D. Relationship between Treatment Center Case Volume and Outcomes for Ewing Sarcoma Patients: The Role of Local Therapy Timing. International Journal of Radiation Oncology • Biology • Physics (IJROBP).
Book Chapters
- Farooqi A, Yeboa DN, Sulman. Low Grade Gliomas. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-1, 2019.
- Farooqi A, Yeboa DN, Sulman. High Grade Gliomas. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-4, 2019.
- Farooqi A, Yeboa DN, Sulman. Meningioma. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-8, 2019.
- Farooqi A, Yeboa DN, Sulman. Pituitary Adenoma and Craniopharyngioma. In: Pocket Radiation Oncology. 1. Wolters Kluwer, 3-15, 2019.
- Ferguson SD, Everson R, Wagner K, Yeboa DN, McCutcheon IE, Sawaya R. Neurosurgical Management of Single Brain Metastases. In: Adult CNS Radiation Oncology: Principles and Practice. 1st. Springer: Switzerland, 431-448, 2018.
- Yeboa DN, Young M, Damast, S.. Vaginal Cancer. In: Pocket Guide to Radiation Oncology. 1st. Demos Medical Publishing, 2016.
Grant & Contract Support
| Title: | Transforming the Standard of Care: A Personalized Approach for Patients with Cancer Metastatic to the Brain |
| Funding Source: | Brockman Foundation Medical Research Grant |
| Role: | Principal Investigator |
| Title: | R25 For Diversity Pipeline (Dr. Travis) / Partnership for Diversity |
| Funding Source: | NIH Letter of Support |
| Role: | Future Mentor Participant |
| Title: | Comparative Effectiveness Outcomes of Gliomas |
| Funding Source: | MD Anderson Cancer Center Start Up Funds |
| Role: | Principal Investigator |
| Title: | Comparative Effectiveness Outcomes of Anaplastic Gliomas |
| Funding Source: | MD Anderson Cancer Center Support Grant (CCSG) New Faculty Funding |
| Role: | Principal Investigator |
| Title: | Evaluating Spine Motion for Feasibility of Spine Radiosurgery on MR LINAC |
| Funding Source: | MD Anderson Radiation Oncology Seed Grant: Advanced Imaging Initiative Funding for MR-LINAC Projects |
| Role: | Principal Investigator |
| Title: | Pre-operative Stereotactic Radiosurgery (SRS) Versus Post-operative SRS for Brain Metastases |
| Funding Source: | MD Anderson Cancer Center Institutional Research Grant |
| Role: | Principal Investigator |
| Title: | Pre-operative Stereotactic Radiosurgery (SRS) Versus Post-operative SRS for Brain Metastases |
| Funding Source: | Shirley Stein Scientific Endowment Research Award |
| Role: | Principal Investigator |
| Title: | Innovating brain cancer management by revolutionizing stereotactic radiotherapy for surgical brain metastases |
| Funding Source: | Robert Wood Johnson Foundation |
| Role: | Principal Investigator |